Author

Regina Jin

Medical University of ViennaORCID 0009-0004-2489-3074Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Ananya MukundaniD· 1 shared Andrew P. HinckiD· 1 shared Anneke SandersiD· 1 shared Chang‐Hyeock ByeoniD· 1 shared Christina SchoenherriD· 1 shared Claire Ciancia· 1 shared Cynthia S. HinckiD· 1 shared Danielle J. SmythiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ananya MukundanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 2, 2026

JAK1/2 Inhibition Restores Tissue Integrity by Rewiring Type 1/2 Immunity Toward Targetable IL-17 Responses

Regina Jin, Karoline Strobl, Lena Artner-Gent…·Thomas Bauer

This study shows JAK1/2 inhibition reduces pathogenic immune responses and restores tissue integrity in chronic skin inflammation by shifting immunity toward IL-17 responses.

DOI 10.64898/2026.10.30.763025

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologyEMBO ReportsPeer-reviewedNov 28, 2024

The helminth TGF-beta mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-beta receptors to preferentially target myeloid cells

Shashi Prakash Singh, Danielle J. Smyth, Kyle T. Cunningham…·Rick M. Maizels

This paper identifies TGM4, a helminth TGF-beta mimic, as a modular ligand that selectively targets myeloid cells through specific receptor interactions, differing from TGM1's broader T cell targeting.

12 citations

mouseexperimental assay

𝕏 PostBluesky